WHO ICTRP trial
Long-term study evaluating joint health in people with haemophilia A receiving…
CTIS2024-517812-31-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-517812-31-00 |
|---|---|
| Public title | Long-term study evaluating joint health in people with haemophilia A receiving real-world prophylactic treatment with efanesoctocog alfa |
| Scientific title | A low-interventional study to evaluate long-term effectiveness of real-world prophylactic treatment with efanesoctocog alfa on joint health in people with haemophilia A (ALTITUDE) - Sobi.BIVV001-005 |
| Primary sponsor | Swedish Orphan Biovitrum AB (publ) |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes |
| Countries | Kuwait;Saudi Arabia;United Kingdom;Czechia;Germany;Ireland;Spain;Sweden;Croatia;Italy;France |
| Conditions | Haemophilia A MedDRA version: 20.0Level: LLTClassification code: 10018937Term: Haemophilia A Class: 10010331;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] |
| Interventions | Product Name: ALTUVOCT 250 IU powder and solvent for solution for injection, Product Code:PRD11427583, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: ALTUVOCT 3 000 IU powder and solvent for… |
| Registration date | Dec 20, 2024 |
| Target size | 235 |
| Secondary IDs | U1111-1312-9668 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: